Meropenem-induced alteration of the susceptibility of Escherichia coli and Staphylococcus aureus to the bactericidal activity of human polymorphonuclear leucocytes

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 2, 1997, Pages 223-228

  Herrera Insua I ^a   Perez P ^a   Martinez P ^a   Gomez Lus M L ^a   Prieto, J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM; IMIPENEM; MEROPENEM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CELL KILLING; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL; PHAGOCYTOSIS; STAPHYLOCOCCUS AUREUS;

BLOOD BACTERICIDAL ACTIVITY; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; NEUTROPHILS; STAPHYLOCOCCUS AUREUS; THIENAMYCINS;

EID: 1842331504     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.2.223     Document Type: Article

References (33)

1. Weinstein, L. & Dalton, A. C. (1968). Host determinants of response to antimicrobial agents. New England Journal of Medicine 279, 524-31.
2. Silletti, R. P. (1986). Effect of sublethal concentrations of antibiotics on the immune system. In Antimicrobial Agents and Immunity (Jeljaszewicz, J. & Pulverer, G., Eds), pp. 157-88. Academic Press, London.
3. Wiseman, L. R., Wagstaff, A. J., Brogden, R. N. & Bryson, H. M. (1995). Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 50, 73-101.
4. Jones, R. N., Barry, A. L., Gavan, T. L. & Washington, J. A. (1985). Susceptibility test: microdilution and macrodilution broth procedures. In Manual of Clinical Microbiology, 4th edn (Lennette, E. H., Balows, A., Hausler, W. J. & Shadomy, H. J., Eds), pp. 972-7. American Society for Microbiology, Washington, DC.
5. Eggleton, P., Gargan, R. & Fisher, D. (1989). Rapid method for the isolation of neutrophils in high yield without the use of dextran or density gradient polymers. Journal of Immunological Methods 121, 105-13.
6. McDonald, P. J., Wetherall, B. L. & Pruul, H. (1981). Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes. Reviews of Infectious Diseases 3, 38-44.
7. Gargan, R. A., Brumfitt, W. & Hamilton-Miller, J. M. T. (1989). Failure of water to lyse polymorphonuclear neutrophils completely. Role of pH and implications for assessment of bacterial killing. Journal of Immunological Methods 124, 289-91.
8. Van der Auwera, P. (1983). The immunomodulating effects of antibiotics. Current Opinion in Infectious Diseases 1, 363-74.
9. van den Broek, P. J. (1989). Antimicrobial drugs, microorganisms, and phagocytes. Reviews of Infectious Diseases 11, 213-45.
10. Carlone, N. A., Cuffini, A. M., Tullio, V. & Cavallo, G. (1991). Interactions of antibiotics with phagocytes in-vitro. Journal of Chemotherapy 3, Suppl. 1, 98-104.
11. Bax, R. P., Bastain, W., Featherstone, A., Wilkinson, D. M., Hutchison, M. & Haworth, S. J. (1989). The pharmacokinetics of meropenem in volunteers. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 311-20.
12. Drusano, G. L., Standiford, H. C., Bustamante, C., Forrest, A., Rivera, G., Leslie, J. et al. (1984). Multiple-dose pharmacokinetics of imipenem-cilastatin. Antimicrobial Agents and Chemotherapy 26, 715-21.
13. Wu, Q., Wang, Q., Taylor, K. G. & Doyle, R. J. (1995). Subinhibitory concentrations of antibiotics affect cell surface properties of Streptococcus sobrinus. Journal of Bacteriology 177, 1399-401.
14. Pruul, H., Lewis, G. & McDonald, P. J. (1988). Enhanced susceptibility of Gram-negative bacteria to phagocytic killing by human polymorphonuclear leucocytes after brief exposure to aztreonam. Journal of Antimicrobial Chemotherapy 22, 675-86.
15. Pruul, H. & McDonald, P. J. (1988). Damage to bacteria by antibiotics in vitro and its relevance to antimicrobial chemotherapy: a historical perspective. Journal of Antimicrobial Chemotherapy 21, 695-8.
16. Hart, R. F., Reynard, A. M. & Cunningham, R. K. (1982). Effects of antibiotics on the bactericidal activity of normal human serum. In The Influence of Antibiotics on the Host-Parasite Relationship (Eickenberg, H.-U., Hahn, H. & Opferkuch, W., Eds), pp. 255-62. Springer-Verlag, Berlin.
17. Milatovic, D., Braveny, I. & Verhoef, J. (1983). Clindamycin enhances opsonization of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 24, 413-7.
18. Veringa, E. M. & Verhoef, J. (1987). Clindamycin at subinhibitory concentrations enhances antibody- and complement-dependent phagocytosis by human polymorphonuclear leukocytes of Staphylococcus aureus. Chemotherapy 33, 243-9.
19. Raponi, G., Keller, N., Rozenberg-Arska, M., Hoepelman, I. M. & Verhoef, J. (1989). The influence of cefepime on opsonophagocytosis of bacteria. Drugs under Experimental and Clinical Research 15, 141-4.
20. García, I., Pascual, A., Guzmán, M. C. & Perea, E. J. (1991). Efecto de miocamicina y eritromicina en la actividad de los neutrófilos humanos sobre Staphylococcus aureus. Enfermedades Infecciosas y Microbiología Clínica 9, 459-63.
21. Mandell, L. A. & Afnan, M. (1991). Mechanisms of interaction among subinhibitory concentrations of antibiotics, human polymorphonuclear neutrophils, and Gram-negative bacilli. Antimicrobial Agents and Chemotherapy 35, 1291-7.
22. Cuffini, A. M., Tullio, V., Allocco, A., Giachino, F., Fazari, S. & Carlone, N. A. (1993). The entry of meropenem into human macrophages and its immunomodulating activity. Journal of Antimicrobial Chemotherapy 32, 695-703.
23. Baquero, F., Culebras, E., Patrón, C., Pérez-Díaz, J. C., Medrano, J. C. & Vicente, M. F. (1986). Postantibiotic effect of imipenem on Gram-positive and Gram-negative micro-organisms. Journal of Antimicrobial Chemotherapy 18, Suppl. E, 47-59.
24. Nadler, H. L., Pitkin, D. H. & Sheikh, W. (1989). The post-antibiotic effect of meropenem and imipenem on selected bacteria. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 225-31.
25. Daschner, F. D. (1985). Antibiotics and host defence with special reference to phagocytosis by human polymorphonuclear leukocytes. Journal of Antimicrobial Chemotherapy 16, 135-41.
26. Pruul, H. & McDonald, P. J. (1993). Cefdinir-induced modification of the susceptibility of bacteria to the antibacterial activity of human serum and polymorphonuclear neutrophils. European Journal of Clinical Microbiology & Infectious Diseases 12, 170-6.
27. Watanabe, Y., Tawara, S., Mine, Y., Kikuchi, H., Goto, S. & Kuwahara, S. (1986). Synergism of cephalosporins at subinhibitory concentrations and polymorphonuclear leukocytes on phagocytic killing of Escherichia coli and its mode of action. Journal of Antibiotics 39, 294-303.
28. Milatovic, D. (1983). Antibiotics and phagocytosis. European Journal of Clinical Microbiology 2, 414-25.
29. Gnarpe, H. & Belsheim, J. (1986). Interaction of antibiotics with granulocytes and linfocytes. In Antimicrobial Agents and Immunity (Jeljaszewicz, J. & Pulverer, G., Eds), pp. 131-55. Academic Press, London.
30. Hand, W. L., King-Thompson, N. & Holman, J. W. (1987). Entry of roxithromycin (RU 965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes. Antimicrobial Agents and Chemotherapy 31, 1553-7.
31. Easmon, C. S. F. (1989). Interaction of meropenem with humoral and phagocytic defences. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 259-64.
32. Solberg, C. O. (1978). Effect of antibiotics on the bactericidal activity of human leucocytes. Infection 6, Suppl. 1, 116-9.
33. Received 2 December 1994; returned 31 January 1995; revised 1 May 1996; accepted 6 September 1996